v3.10.0.1
Income Taxes
12 Months Ended
Dec. 31, 2018
Income Tax Disclosure [Abstract]  
Income Taxes

9. Income Taxes

The domestic and foreign components of pre-tax loss were as follows:

 

 

 

Year Ended December 31,

 

 

 

2016

 

 

2017

 

 

2018

 

 

 

 

 

 

 

(in thousands)

 

 

 

 

 

Domestic

 

$

(520,482

)

 

$

(3,027,580

)

 

$

(969,922

)

Foreign

 

 

(1,241

)

 

 

(435,828

)

 

 

(283,442

)

Loss before income taxes

 

$

(521,723

)

 

$

(3,463,408

)

 

$

(1,253,364

)

 

The components of our income tax (benefit) expense were as follows:

 

 

 

Year Ended December 31,

 

 

 

2016

 

 

2017

 

 

2018

 

 

 

 

 

 

 

(in thousands)

 

 

 

 

 

Current:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

 

 

$

 

 

$

 

State

 

 

3

 

 

 

(1,784

)

 

 

106

 

Foreign

 

 

869

 

 

 

932

 

 

 

2,824

 

Total current income tax (benefit) expense

 

 

872

 

 

 

(852

)

 

 

2,930

 

Deferred:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

 

(6,364

)

 

 

(12,287

)

 

 

(15

)

State

 

 

(780

)

 

 

303

 

 

 

(40

)

Foreign

 

 

(808

)

 

 

(5,506

)

 

 

(328

)

Total deferred income tax (benefit) expense

 

 

(7,952

)

 

 

(17,490

)

 

 

(383

)

Income tax (benefit) expense

 

$

(7,080

)

 

$

(18,342

)

 

$

2,547

 

 

The following is a reconciliation of the statutory federal income tax rate to our effective tax rate:

 

 

 

Year Ended December 31,

 

 

 

2016

 

 

2017

 

 

2018

 

Tax benefit (expense) computed at the federal statutory rate

 

 

34.0

%

 

 

34.0

%

 

 

21.0

%

State tax benefit (expense), net of federal benefit

 

 

1.3

 

 

 

3.0

 

 

 

5.1

 

Change in valuation allowance

 

 

(34.6

)

 

 

(25.4

)

 

 

(28.4

)

U.S. corporate tax rate reduction

 

 

 

 

 

(11.4

)

 

 

0.2

 

Differences between U.S. and foreign tax rates on foreign income

 

 

 

 

 

(2.4

)

 

 

(0.9

)

Stock-based compensation benefit (expense)

 

 

(0.4

)

 

 

1.1

 

 

 

(1.2

)

U.S. federal research & development credit benefit

 

 

1.2

 

 

 

1.4

 

 

 

5.2

 

Other benefits (expenses)

 

 

(0.1

)

 

 

0.2

 

 

 

(1.2

)

Total income tax benefit (expense)

 

 

1.4

%

 

 

0.5

%

 

 

(0.2

)%

 

The significant components of net deferred tax balances were as follows:

 

 

 

Year Ended December 31,

 

 

 

2017

 

 

2018

 

 

 

(in thousands)

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Accrued expenses

 

$

10,534

 

 

$

21,056

 

Deferred revenue

 

 

2,142

 

 

 

976

 

Intangible assets

 

 

140,771

 

 

 

140,494

 

Stock-based compensation

 

 

396,604

 

 

 

254,255

 

Net operating losses

 

 

473,110

 

 

 

849,224

 

Tax credit carryforwards

 

 

124,078

 

 

 

235,300

 

Property and equipment

 

 

 

 

 

203

 

Other

 

 

2,015

 

 

 

322

 

Total deferred tax assets

 

$

1,149,254

 

 

$

1,501,830

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Property and equipment

 

$

(5,883

)

 

$

 

Total deferred tax liabilities

 

 

(5,883

)

 

 

 

Total net deferred tax assets before valuation allowance

 

 

1,143,371

 

 

 

1,501,830

 

Valuation allowance

 

 

(1,144,543

)

 

 

(1,502,346

)

Net deferred taxes

 

$

(1,172

)

 

$

(516

)

 

Income tax expense was $2.5 million for the year ended December 31, 2018, compared to a tax benefit of $18.3 million for the year ended December 31, 2017. The income tax benefit in the prior period was primarily from the partial release of a valuation allowance against our net deferred tax assets that was not in the current period. The valuation allowance release was the result of net deferred tax liabilities originating from acquisitions that were an available source of income to realize a portion of our deferred tax assets.

On December 22, 2017, the Tax Cuts and Jobs Act of 2017 (“Tax Act”) was signed into law making significant changes to the Internal Revenue Code of 1986, as amended (“Code”). Changes include, but are not limited to, a corporate tax rate decrease to 21% effective for tax years beginning after December 31, 2017.

In December 2017, the SEC staff issued Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (“SAB 118”), which allows us to record provisional amounts during a measurement period not to extend beyond one year of the enactment date. In accordance with SAB 118, a company must reflect the income tax effects of those aspects of the Tax Act for which the accounting under ASC 740 is complete. To the extent that a company’s accounting for certain income tax effects of the Tax Act is incomplete but a reasonable estimate can be determined, it must record a provisional estimate in the financial statements.

In the period ended December 31, 2017, we recorded a provisional $396.2 million reduction in our net U.S. deferred tax assets before valuation allowance from the re-measurement of our U.S. deferred tax balances from 34% to the new 21% tax rate. This amount has been updated to $393.4 million for the period ended December 31, 2018. The change to our net U.S. deferred tax assets in both periods is fully offset by a change to our valuation allowance. For purposes of SAB 118, we consider our accounting for the income tax impacts of the Tax Act complete.

The Tax Act also introduced the global intangible low-taxed income (“GILTI”) provisions that impose a tax on foreign income in excess of a deemed return on tangible assets of foreign corporations. We recognize the tax on GILTI as an expense in the period the tax is incurred. We have not provided deferred taxes related to temporary differences that on their reversal will affect the amount of income subject to GILTI in the period.

As of December 31, 2018, we had an immaterial amount of unremitted earnings related to certain foreign subsidiaries. We intend to continue to reinvest our foreign earnings indefinitely and do not expect to incur any significant taxes related to such amounts.

As of December 31, 2018, we had accumulated federal and state net operating loss carry-forwards of $2.8 billion and $1.5 billion, respectively. Of the $2.8 billion of federal net operating loss carry-forwards, $1.5 billion was generated before January 1, 2018 and is subject to the 20-year carryforward period (“pre-Tax Act losses”). The remaining $1.3 billion (“post-Tax Act losses”) can be carried forward indefinitely but is subject to the 80% taxable income limitation. The pre-Tax Act U.S. federal and state net operating loss carry-forwards will begin to expire in 2031 and 2026, respectively. As of December 31, 2018, we had $911.6 million of U.K. net operating loss-carryforwards that can be carried over indefinitely. As of December 31, 2018, we had accumulated U.S. federal and state research tax credits of $159.8 million and $90.5 million, respectively. The U.S. federal research tax credits will begin to expire in 2032. The U.S. state research tax credits do not expire.

Available net operating losses may be subject to annual limitations due to ownership change limitations provided by the Code, and similar state provisions. Under Section 382 of the Code, substantial changes in our ownership and the ownership of acquired companies may limit the amount of net operating loss carry-forwards that are available to offset taxable income. The annual limitation would not automatically result in the loss of net operating loss carry-forwards but may limit the amount available in any given future period. Additional limitations on the use of these tax attributes could occur in the event of possible disputes arising in examination from various taxing authorities.

We recognize valuation allowances on deferred tax assets if it is more likely than not that some or all of the deferred tax assets will not be realized. We had valuation allowances against net deferred tax assets of $1.5 billion and $1.1 billion as of December 31, 2018 and 2017, respectively. In 2018, the change in the valuation allowance was primarily attributable to a net increase in our deferred tax assets resulting from the loss from operations.

Uncertain Tax Positions

The following table summarizes the activity related to our gross unrecognized tax benefits during the years ended December 31, 2018 and 2017:

 

 

 

Year Ended December 31,

 

 

 

2017

 

 

2018

 

 

 

(in thousands)

 

Beginning balance of unrecognized tax benefits

 

$

243,862

 

 

$

203,177

 

Additions for current year tax positions

 

 

42,209

 

 

 

43,197

 

Additions for prior year tax positions

 

 

2,158

 

 

 

7,615

 

Reductions for prior year tax positions

 

 

(568

)

 

 

(1,965

)

Changes due to foreign currency translation adjustments

 

 

163

 

 

 

(216

)

Remeasurement of uncertain tax positions due to the Tax Act

 

 

(84,647

)

 

 

 

Ending balance of unrecognized tax benefits (excluding interest and penalties)

 

$

203,177

 

 

$

251,808

 

Interest and penalties associated with unrecognized tax benefits

 

 

80

 

 

 

260

 

Ending balance of unrecognized tax benefits (including interest and penalties)

 

$

203,257

 

 

$

252,068

 

 

The total amount of gross unrecognized tax benefits, including related interest and penalties, was $252.1 million and $203.3 million as of December 31, 2018 and 2017, respectively. Substantially all of the unrecognized tax benefit was recorded as a reduction in our gross deferred tax assets, offset by a corresponding reduction in our valuation allowance. We have net unrecognized tax benefits of $2.7 million and $2.1 million that is included in other liabilities on our consolidated balance sheet as of December 31, 2018 and 2017, respectively. Assuming there continues to be a valuation allowance against deferred tax assets in future periods when gross unrecognized tax benefits are realized, this would result in a tax benefit of $4.1 million within our provision of income taxes at such time.

Our policy is to recognize interest and penalties associated with tax matters as part of the income tax provision and include accrued interest and penalties with the related income tax liability on our consolidated balance sheet. During the year ended December 31, 2018, interest expense we recorded related to uncertain tax positions was not material. Any changes to unrecognized tax benefits recorded as of December 31, 2018 that are reasonably possible to occur within the next 12 months are not expected to be material.

The income taxes we pay are subject to review by taxing jurisdictions globally. Our estimate of the potential outcome of any uncertain tax position is subject to management’s assessment of relevant risks, facts, and circumstances existing at that time. We believe that our estimate has adequately provided for these matters. However, our future results may include adjustments to estimates in the period the audits are resolved, which may impact our effective tax rate.

Tax years ending on or after December 31, 2012 are subject to examination in the U.S., and tax years ending on or after December 31, 2016 are generally subject to examination in various foreign jurisdictions.